Synopsis: Two Arabidopsis SUMO E3 ligase-like proteins interact with MOM1 and form a complex that mediates transcriptional silencing independently of changes in DNA methylation.
INTRODUCTION
In eukaryotic genomes, transposable elements, DNA repeats, and exogenous transgenes are usually subjected to transcriptional silencing (Slotkin and Martienssen, 2007) . In Arabidopsis thaliana, transcriptional silencing is accompanied by DNA methylation and repressive histone marks (Law and Jacobsen, 2010; Matzkeand Mosher, 2014; Du et al., 2015) . Components involved in DNA methylation and repressive histone modification were previously identified and demonstrated to be required for transcriptional silencing (Law and Jacobsen, 2010; Matzkeand Mosher, 2014; Du et al., 2015) . The DNMT1-like DNA methyltransferase MET1 maintains DNA methylation at symmetric CG sites during DNA replication (Ronemus et al., 1996; Jones et al., 2001 ). DDM1, a SNF2-type chromatin-remodeling protein, allows DNA methyltransferases to access H1-containing heterochromatin (Zemach et al., 2013) .
The plant-specific DNA methyltransferase CMT3 specifically contributes to DNA methylation at CHG sites (Lindroth et al., 2001) . The histone methyltransferases SUVH4/KYP, SUVH5, and SUVH6 mediate H3K9 dimethylation and act together with CMT3 to facilitate a self-reinforcing loop between CHG methylation and H3K9 methylation (Jackson et al., 2002; Ebbs and Bender, 2006; Du et al., 2015) .
DNA methylation at CHH sites is established and maintained by DRM2, a DNMT3-like DNA methyltransferase, and CMT2, a plant-specific DNA methyltransferase (Cao and Jacobsen, 2002; Stroud et al., 2014; Zemach et al., 2013) .
To mediate de novo DNA methylation, DRM2 is guided by an RNA-directed DNA methylation (RdDM) pathway (Law and Jacobsen, 2010; Matzke and Mosher, 2014) . In the RdDM pathway, 24-nucleotide small interfering RNA (siRNA) mediates de novo DNA methylation (Hamilton et al., 2002; Aufsatz et al., 2002; Matzke and Mosher, 2014) . DNA-dependent RNA polymerases IV and V (Pol IV and Pol V) are two multi-subunit DNA-dependent RNA polymerases that are unique to plants (Ream et al., 2009; Huang et al., 2009; Law and Jacobsen, 2010) . NRPD1 and NRPE1 are the largest subunits of Pol IV and Pol V, respectively (Herr et al., 2005; Kanno et al., 2005; Pontier et al., 2005; Ream et al., 2009; Huang et al., 2009) . The generation of 24-nt siRNA is dependent on Pol IV, RNA-dependent RNA polymerase 2 (RDR2), and Dicer-like 3 (DCL3) (Haag and Pikaard, 2011; Xie et al., 2004) . The 24-nt siRNA is loaded into Argonaute 4 (AGO4) and forms an AGO4-siRNA complex that is thought to guide DRM2 to homologous genomic loci (Pontes et al., 2006; Zhong et al., 2014) . Long non-coding RNA produced by Pol V is believed to base-pair with the AGO4-bound siRNA and is required for the occupancy of AGO4-siRNA on chromatin (Wierzbicki et al., 2008; Haag and Pikaard, 2011) .
Alteration of DNA methylation is not always required for transcriptional silencing in Arabidopsis (Amedeo et al., 2000; Vaillant et al., 2006) . The plant-specific CHD3-like protein MOM1 was identified by a forward genetic screen as a unique component in transcriptional silencing (Amedeo et al., 2000) . In the mom1 mutant, transcriptional silencing is released even when DNA methylation is not affected (Amedeo et al., 2000; Vaillant et al., 2006) , suggesting that MOM1 mediates transcriptional silencing through a mechanism that is different from DNA methylation. Although MOM1 mediates H3K9 dimethylation at a few target loci shared by RdDM and MOM1 (Numa et al., 2010) , the involvement of MOM1 in transcriptional silencing at the whole-genome level is independent of changes not only in DNA methylation but also in histone H3K9 dimethylation (Probst et al., 2003; Vaillant et al., 2006) . To understand how MOM1 contributes to transcriptional silencing, a series of truncated MOM1 sequences were transformed into the mom1 mutant for complementation assays (Caikovski et al., 2008) . The results indicated that the conserved C-terminal CMM2 domain is necessary and sufficient for transcriptional silencing at some MOM1 target loci and that the putative SNF2 and DNA helicase domains in MOM1 are dispensable for transcriptional silencing. The CMM2 domain exists in an anti-parallel coiled-coil structure and forms a homodimer required for transcriptional silencing (Nishimura et al., 2012) . These results suggest that MOM1 most likely acts as an adaptor component in a multi-subunit complex rather than as an ATP-dependent chromatin-remodeling enzyme. The molecular mechanism by which MOM1 contributes to transcriptional silencing remains to be elucidated.
Small ubiquitin-related modifier (SUMO) is a conserved posttranscriptional modification in eukaryotes. SUMO proteins are covalently attached to substrate proteins through the activities of an enzyme cascade composed of E1 (SUMO activating enzyme, SAE), E2 (SUMO conjugating enzyme, SCE), and E3 (SUMO ligase) (Gareau and Lima, 2010) . In yeast and animals, SUMO modification is involved in various biological processes including chromatin organization and transcriptional regulation (Shin et al., 2005; Shiio et al. 2003; Nathan et al., 2006; Cobenas-Potts and Matunis, 2013) .
Noncovalent interaction of SUMO proteins with chromatin-associated proteins is also required for SUMO-dependent transcriptional regulation (Stielow et al., 2008; Ouyang et al., 2009; Cobenas-Potts and Matunis, 2013) . In Arabidopsis, mass spectrometric analysis of purified sumoylated proteins demonstrated that many SUMO substrates are involved in chromatin structure regulation, transcription, and RNA metabolism (Budhiraja et al., 2009; Miller et al., 2010) . Moreover, several chromatinassociated proteins were identified by a yeast two-hybrid screen as SUMO-interacting proteins (Elrouby 4 et al., 2013) . It is unknown, however, whether and how SUMO proteins and SUMO-conjugating enzymes contribute to transcriptional silencing in plants.
Arabidopsis has three SUMO E1 activating enzymes (SAE1a, SAE1b and SAE2), two SUMO E2 conjugating enzymes (SCE1a and SCE1b), and four SUMO E3 ligases (SIZ1, HPY2, PIAL1, and PIAL2) (Kurepa et al., 2003; Ishida et al., 2009; Tomanov et al., 2014) . Analyses of mutants defective in these components suggest that they are required not only for growth and development but also for responses to a variety of stresses (Saracco et al., 2007; Miura and Hasegawa, 2010; Tomanov et al., 2014) . SUMO E3 ligases contain a SP(SIZ-PAS)-RING zinc finger domain that is responsible for recruiting E2 to substrates (Gareauand Lima, 2010; Miura and Hasegawa, 2010) . In this study, we carried out a forward genetic screen and identified a SUMO E3 ligase-like protein PIAL2 as a regulator of transcriptional silencing. Our results demonstrate that PIAL2 and its homolog PIAL1 interact with each other and with MOM1 and form a novel complex that mediates transcriptional silencing independently of changes in DNA methylation.
RESULTS

Identification of PIAL2 as a Regulator of Transcriptional Silencing
FWA (FLOWERING WAGENINGEN), a flowering repressor gene, is silenced by DNA methylation at the SINE-type repeats in the FWA transcription start region (Soppeet al., 2000; Kinoshita et al., 2007) .
Previous studies demonstrated that the full-length FWA transgene is an efficient target of DNA methylation and transcriptional silencing (Cao and Jacobsen, 2002; Chan et al., 2004) . Here, we generated a luciferase reporter system under the control of the FWA promoter (pFWA-LUC) to screen for novel regulators of transcriptional silencing (Supplemental Figure 1, 2) . The pFWA-LUC reporter gene was initially transformed into the nrpe1-11 mutant and the reporter gene was expressed at high levels in the transgenic lines. A pFWA-LUC transgenic line was selected and then crossed to the wild-type Col-0.
In the F2 generation, the release of silencing in pFWA-LUC co-segregated with the nrpe1-1 mutation (Supplemental Figure 1, 2) , suggesting that the silencing of the pFWA-LUC reporter gene requires NPRE1, a component of the RNA-directed DNA methylation pathway. A silenced pFWA-LUC transgenic line in the wild-type background was selected from the F2 generation and its offspring were subjected to ethyl methane sulfonate (EMS) mutagenesis to create a mutant library (Supplemental Figure 1 , 2). We screened for mutants that released the silencing of the pFWA-LUC transgene by 5 luminescence imaging and identified the mutations by map-based cloning. Based on the screening, we identified several known RdDM components including AGO4, NRPD1, NRPD2, NRPD4, DRD1,   RDR2, and RDM4/DMS4, and various other silencing regulators including MORC6/DMS11, MOM1, MET1, FPGS1, FAS1, and BRU1 (Supplemental Table 1 ). We also identified a silencing mutant, #84-3, in which the silencing of the pFWA-LUC transgene was released ( Figure 1A ).
We performed RT-qPCR analysis to determine the transcript level of pFWA-LUC and demonstrated that the silencing of pFWA-LUC was released in #84-3 as well as in nrpd1, drd1, and mom1 ( Figure 1B ).
Whole-genome bisulfite sequencing analysis was performed to determine the DNA methylation status of the FWA promoter in the pFWA-LUC transgenic lines in the wild-type, nrpe1, mom1, and #84-3 backgrounds. We found that the DNA methylation level of the FWA promoter was markedly reduced in nrpe1 but not in mom1 and #84-3 ( Figure 1C ), suggesting that #84-3 as well as mom1 released the silencing of pFWA-LUC independently of changes in DNA methylation. By using map-based cloning in combination with whole-genome sequencing, we identified a G to A mutation at a splice site of AT5G41580 in the #84-3 mutant (Supplemental Figure 3A-3C ). AT5G41580 encodes PROTEIN INHIBITOR OF ACTIVATED STAT LIKE2 (PIAL2), which is distantly related to PIAS-type SUMO E3 ligases in animals (Supplemental Figure 4) .
To demonstrate that the mutation in PIAL2 is responsible for the defect in transcriptional silencing, we obtained a homozygous T-DNA pial2 mutant (SALK_043892C, pial2-1) from the Arabidopsis Biological Resource Center (ABRC). Using RT-qPCR analysis, we found that the silencing of the endogenous silencing target loci, including solo LTR, SDC, ROMANIAT5, and AT5TE35950 was released in the pial2-1 mutant ( Figure 1D ). Furthermore, we generated constructs harboring the fulllength PIAL2 genomic fragment fused with the C-terminal Flag or Myc tag and transformed the constructs into the pial2-1 mutant for complementation assays. The results indicated that the PIAL2-Flag and PIAL2-Myc transgenes restored the silencing of these loci in the pial2 mutant ( Figure 1D ), demonstrating that PIAL2 is required for transcriptional silencing.
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PIAL2 is Involved in the Silencing of the RD29A-LUC Transgene in the ros1 Mutant
We previously identified silencing regulators using a pRD29A-LUC reporter system in the DNA demethylation mutant ros1 (He et al., 2009 ). The pRD29A-LUC reporter gene was silenced when the DNA demethylation component ROS1 was disrupted (Gong et al., 2002) . By a genetic screen for suppressors of ros1, we identified many RdDM components that mediate the silencing of the pRD29A-LUC in the ros1 mutant background (He et al., 2009) . Here, our further genetic screen identified mom1 as a suppressor of ros1 in the pRD29A-LUC reporter system ( Figure 1E ). To determine whether PIAL2 contributes to the silencing of the RD29A-LUC reporter gene in the ros1 mutant background, we crossed pial2-1 to ros1 to obtain a ros1/pial2 double mutant harboring the pRD29A-LUC reporter gene. We found that silencing of the pRD29A-LUC reporter gene was released not only in ros1/mom1 but also in ros1/pial2 ( Figure 1E ). The result demonstrates that PIAL2 as well as MOM1 are involved in the silencing of the pRD29A-LUC transgene in the ros1 mutant background.
PIAL1 and PIAL2 Function Redundantly in Transcriptional Silencing
PIAL2 has a homolog, PIAL1, in Arabidopsis and is highly conserved, especially at the N-terminal regions, in plants (Supplemental Figure 5) . It is possible that PIAL1 functions redundantly with PIAL2 to mediate transcriptional silencing. We obtained a homozygous T-DNA pial1 mutant (CS358389) from ABRC and crossed the pial1 mutant with the T-DNA pial2 mutant to create a pial1 pial2 (pial1/2) double mutant. As determined by RT-qPCR analysis, the transcript levels of solo LTR, SDC, ROMANIAT5, and AT5TE35950 were markedly increased in pial2 and were either not increased or weakly increased in pial1. Moreover, the transcript levels of these loci were significantly higher in the pial1/2 double mutant than in either of the single mutants ( Figure 1F ), suggesting that the function of PIAL1 and PIAL2 in transcriptional silencing is partially redundant. We thereafter analyzed the function of PIAL1 and PIAL2 together in the pial1/2 double mutant.
PIAL1 and PIAl2 Share Common Targets with MOM1
Several well-known genomic loci were commonly used as MOM1 and/or RdDM targets in previous reports (Steimer et al., 2000; Yokthongwattana et al., 2010; Numa et al., 2010; He et al., 2009; Blevins et al., 2014) . We examined the transcript levels of these loci in mom1, nrpe1, and pial1/2 by RT-qPCR analysis. Based on the expression patterns of these loci, we divided these loci into three classes ( Figure   2A ). Class I loci are markedly up-regulated in mom1 and pial1/2 but are either not up-regulated or are weakly up-regulated in nrpe1; Class II loci are up-regulated in all three mutants; and Class III loci are markedly up-regulated in nrpe1 but are either not up-regulated or are weakly up-regulated in mom1 and pial1/2. The RT-qPCR results indicated that the expression patterns in mom1 and pial1/2 are almost the same but are different from that in nrpe1 ( Figure 2A ). Previous studies reported that the transcript level of ROS1 is decreased in mutants defective in the RdDM pathway (Huettel et al., 2006; He et al. 2009 ).
Our RT-qPCR result indicated that although the ROS1 transcript level is decreased in the RdDM mutant nrpe1, it is not decreased in pial1/2 or mom1 ( Figure 2A ). These results suggest that PIAL1/2 and MOM1 are not components of the RdDM pathway.
To compare the targets of NRPE1, MOM1, and PIAL1/2 at the whole-genome level, we performed Figure 2C ). These results demonstrate that PIAL1 and PIAL2 contribute to transcriptional silencing at most MOM1 target loci.
To determine the genetic relationship between MOM1 and PIAL2, we performed RNA deep sequencing to analyze the transcript levels of MOM1 and PIAL1/2 common target TEs in the wild type, mom1, pial2, and mom1pial2. We found that the silencing of MOM1 and PIAL1/2 common target TEs was markedly released in mom1 and is slightly released in pial2 ( Figure 2D ). The weak effect of pial2 supports the notion that PIAL2 functions redundantly with PIAL1 in transcriptional silencing. The release of silencing in MOM1 and PIAL1/2 common target TEs was not significantly enhanced in the mom1 pial2 double mutant relative to the mom1 single mutant ( Figure 2D ), suggesting that MOM1 and PIAL2 function in the same pathway.
RdDM components tend to target the euchromatic regions of chromosome arms (Huettel et al, 2006; Cokus et al., 2008; Zemach et al., 2013) , whereas MOM1 preferentially targets pericentromeric heterochromatin regions (Habu et al, 2006; Yokthongwattana et al., 2010) . We localized up-regulated TEs identified in nrpe1, mom1, and pial1/2 on five Arabidopsis chromosomes. The results suggest that PIAL1/2 and MOM1 tend to target TEs in pericentromeric heterochromatin regions, whereas NRPE1 tends to target TEs in euchromatic regions ( Figure 2E ). Long TEs are preferentially enriched in pericentromeric heterochromatin regions, whereas short TEs are mostly present at the intergenic regions of chromosome arms (Ahmed et al., 2011; Zemach et al., 2013) . We found that TEs targeted by PIAL1/2 and MOM1 are markedly longer than those targeted by NRPE1 ( Figure 2F ). These results suggest that PIAL1/2 and MOM1 function together to mediate transcriptional silencing in heterochromatin regions.
The Involvement of PIAL1 and PIAL2 in Transcriptional Silencing is Independent of Changes in
DNA Methylation
We performed whole-genome bisulfite sequencing analysis in the wild type, nrpe1, mom1, and pial1/2. DNA methylation was separately analyzed at total C, CG, CHG, and CHH sites for differentially methylated regions (DMRs). When DNA methylation of total C was analyzed, 5402 hypomethylatedDMRs (hypo-DMRs) were identified in nrpe1 ( Figure 3A ). When CG, CHG, and CHH sites were separately analyzed for DMRs, the number of CHH hypo-DMRs (5261) identified in nrpe1 is much higher than the numbers of CG hypo-DMRs (313) and CHG hypo-DMRs (874) (Supplemental Figure 7A) , which supports the notion that the RdDM pathway affects DNA methylation especially at CHH sites. MOM1 was believed to mediate transcriptional silencing without changes in DNA methylation (Amedeo et al., 2000; Vaillant et al., 2006) . When DNA methylation of total C was analyzed, 591 and 509 hypo-DMRs were identified in mom1 and pial1/2, respectively, which are much lower than number of the hypo-DMRs identified in npre1 ( Figure 3A) . When the three different cytosine contexts CG, CHG and CHH were separately analyzed, the numbers of hypo-DMRs are comparable in mom1 and pial1/2, and are much lower than in nrpe1 (Supplemental Figure 7A ). In the hypo-DMRs identified in nrpe1, DNA methylation is only slightly reduced in mom1 and pial1/2 ( Figure 3B ; Supplemental Figure 7B ). Heat maps indicated that the DNA methylation patterns of mom1 and pial1/2 are similar and are comparable to that of the wild type but are different from that of the RdDM mutant nrpe1 ( Figure 3C ).
We next determined whether the up-regulation of TEs and genes is correlated with the weak reduction of DNA methylation in mom1 and pial1/2. Our whole-genome bisulfite sequencing data suggest that DNA methylation of transcriptionally up-regulated TEs in nrpe1 is preferentially reduced 
PIAL1, PIAL2, and MOM1 Interact with each other and Form a High-molecular-weight Complex
To determine how PIAL2 functions in transcriptional silencing, we purified PIAL2-interacting proteins from Flag-PIAL2 transgenic plants using anti-Flag antibody. MOM1 peptides were identified by mass spectrometric analysis in PIAL2-copurified proteins ( Figure 4A ; Supplemental Data Set 7). Moreover, we purified MOM1-interacting proteins from MOM1-Flag transgenic plants and identified PIAL2 (D and E) DNA methylation levels of transcriptionally up-regulated TEs or genes are shown by box plots (D) and scatter plots (E) in nrpe1, mom1, and pial1/2 relative to the wild type. *p<0.05 or **p<0.01 was determined by t test. In the box plots, gene promoters were included for DNA methylation analysis only when their DNA methylation levels in the wild type were higher than 5%.
peptides in MOM1-copurified proteins ( Figure 4A ; Supplemental Data Set 7). These results suggest that PIAL2 physically interacts with MOM1 to form a complex in vivo, which is consistent with the coexpression between PIAL2 and MOM1 (Obayashi et al., 2009) . Interestingly, two previously uncharacterized proteins were also identified by mass spectrometric analysis of MOM1-copurified proteins ( Figure 4A ). One (AT4G11560) was named BDT1 (Bromo-adjacent homology (BAH) domaincontaining transcriptional regulator 1); the other (AT1G43770) was named PHD1 (PHD domaincontaining protein 1). BDT1 was identified not only in MOM1-copurified proteins but also in PIAL2-copurified proteins ( Figure 4A ). Both the BAH domain and the PHD domain typically interact with histones or other chromatin-related proteins. It is possible that BDT1 and PHD1 act as components of the MOM1-containing complex on chromatin.
Although PIAL1 and PIAL2 function redundantly in transcriptional silencing, the mass spectrometric analysis identified PIAL2 but not PIAL1 in MOM1-copurified proteins. We performed coimmunoprecipitation (co-IP) analysis to determine whether MOM1 interacts with PIAL1 as well as PIAL2. Transgenic plants harboring the PIAL1 or PIAL2 genomic sequence fused to a Myc tag were generated and crossed to the transgenic plants harboring the MOM1-Flag fusion transgene. Plants from the F1 generation were used to determine the interaction between MOM1 and PIAL1 or PAL2 by co-IP.
The results indicated that MOM1-Flag copurified with PIAL1-Myc as well as PIAL2-Myc ( Figure 4B ), demonstrating that both PIAL1 and PIAL2 interact with MOM1 in vivo. MOM1 was previously demonstrated to contain a conserved MOM1 motif (CMM2), which is sufficient for the function of MOM1 in transcriptional silencing at a subset of MOM1 target loci (Caikovski et al., 2008; Nishimura et al., 2012) . The bacterially expressed CMM2 domain folds into an unusual hendecad-based coiled-coil structure and forms a homodimer as determined by X-ray crystallography (Nishimura et al., 2012) . The interaction between PIAL1, PIAL2, and MOM1 suggests that these proteins form a complex in vivo. We examined whether PIAL1, PIAL2 and MOM1 exist in a complex by gel filtration. Proteins were extracted from epitope-tagged transgenic plants and were separated on a Superose 6 (10/300 GL) column; the eluted fractions were detected by immunoblotting. We found that PIAL1-Myc and PIAL2-Myc were predominantly eluted in fractions of ~220 KDa, whereas MOM1 was absent in these fractions ( Figure 4C ). The ~220 KDa faction is much higher than the PIAL1 or PIAL2 monomer and corresponds to the PIAL1 and/or PIAL2 dimer. Given the interaction of PIAl2 with PIAL1 and PIAL2 as determined by co-IP ( Figure 4B ), PIAL1 and/or PIAl2 may form a homodimer or a heterodimer in vivo. Moreover, the elution of PIAL1 and PIAL2 was extended to fractions of > 669 KDa, whereas MOM1 was present in the fractions ( Figure 4C ), suggesting that PIAL1/2 and MOM1 form a high-molecular-weight complex in the fractions. To determine whether MOM1 is required for PIAL2 to form a complex, we expressed the PIAL2-Myc transgene in the mom1 mutant. The gel filtration result indicated that the elution of PIAL2 disappeared in the high-molecular-weight fractions in the mom1 mutant ( Figure 4C ), suggesting that MOM1 is required for the formation of the high-molecular-weight PIAL2-containing complex. Furthermore, we expressed the MOM1-Myc transgene in the pial1/2 double mutant to determine whether the pial1/2 mutation affects the MOM1 elution pattern in the gel filtration assay. Our result indicated that although MOM1 forms a complex in the pial1/2 mutant, the complex is clearly smaller than that in the wild type ( Figure 4C ), suggesting that PIAL1 and PIAL2 are required for the formation of the high-molecular-weight MOM1-containing complex. Our co-IP result demonstrated that MOM1 forms a homodimer ( Figure 4B ). The remaining MOM1-containing complex in the pial1/2 mutant may at least contain a MOM1 homodimer. Together, these results suggest that PIAL1, PIAL2, and MOM1 interact with each other and form a high-molecular-weight complex in vivo.
14 The IND Domains of PIAL1 and PIAL2 Interact with each other and with the CMM2 Domain of
MOM1
The interaction of MOM1 with PIAL1 or PIAl2 was confirmed by yeast two-hybrid analysis ( Figure 5A , 5B). To determine the interaction domain of MOM1, we performed yeast two-hybrid analysis with truncated versions of MOM1. MOM1 contains a domain that is distantly related to a part of the catalytic 
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SUMO Ligase Activity is not Required for the Function of PIAL2 in Transcriptional Silencing
PIAL2 contains a RING zinc finger motif (RING) and a SUMO interaction motif (SIM), which are necessary for the SUMO ligase activity of PIAL2; mutations in RING and SIM impair the SUMO ligase activity of PIAL2 (Tomanov et al., 2014) . We introduced mutations into the RING and SIM domains (RING-M: C329A/H331A; SIM-M: VFDL425AAAA) and performed a sumoylation assay to determine the effect of the RING and SIM mutations on the SUMO ligase activity of PIAL2 ( Figure 6A ). The The interaction of the CMM2 domain with truncated forms of PIAL2 as determined by yeast two-hybrid assays. The full-length PIAL2 and truncated forms of PIAL2 were fused with GAL4-AD, and the CMM2 domain of MOM1 was fused with GAL4-BD. (E) The IND domains of PIAL1 and PIAL2 interact with each other and with the CMM2 domain of MOM1 as determined by GST pull-down assays. PIAL1-IND, 143-301 aa; PIAL2-IND, 113-271 aa; MOM1-CMM2, 1700-1824 aa. GST-and HIS-tagged proteins were coexpressed in E. coli, and were purified with anti-GST antibody.
result indicated that the SUMO ligase activity of PIAL2 was abolished by the mutation in the RING domain (C329A/H331A) and was partially affected by the mutation in the SIM domain (VFDL425AAAA) ( Figure 6A ). To determine whether the SUMO ligase activity is required for transcriptional silencing, we introduced the RING and SIM mutations into the full-length PIAL2 construct and carried out complementation assays in the pial2 mutant. The expression levels of the wildtype and mutated PIAL2 transgenes were determined by immunoblot analysis in randomly selected transgenic lines. We found that the expression levels of the mutated transgenes PIAL2-RING-M and PIAL2-RING-SIM-M were markedly lower than that of the wild-type PIAL2 transgene, whereas the expression level of the mutated transgene PIAL2-SIM-M was only slightly lower than that of the wild- The interaction between PIAL2 and MOM1 suggests that MOM1 is probably a substrate of sumoylation. Prediction of sumoylated lysine sites using the SUMOylation prediction website (http://sumosp.biocuckoo.org/) indicated that the lysine sites in MOM1 most likely to be sumoylated are K674, K1204, and K1762. To determine whether the sumoylation of MOM1 is required for transcriptional silencing, we mutated the three lysine sites to arginine to block the possible sumoylation of these sites, and we then transformed each of the mutated MOM1 sequences into the mom1 mutant for complementation testing. RT-PCR analysis indicated that the silencing of the MOM1 target loci solo LTR and PDR10 was restored by the mutated MOM1 sequences as well as by the wild-type MOM1 sequence ( Figure 6D ), suggesting that even if MOM1 is sumoylated at these lysine sites, sumoylation is not required for the function of MOM1 in transcriptional silencing. To determine whether MOM1 is sumoylated, we precipitated the MOM1-Flag protein from the MOM1-Flag transgenic plants with antiFlag antibody and determined whether a sumoylated MOM1 signal was present. No sumoylated MOM1 signal was detected by immunoblot analysis ( Figure 6E ). These results suggest that MOM1 is not a substrate of sumoylation even though MOM1 interacts with the SUMO E3 ligase-like proteins PIAL1 and PIAL2. 
DISCUSSION
PIAS proteins were initially identified as protein inhibitors of activated STAT in animals (Chung et al., 1997; Liu et al., 1998) . Later, these proteins were found to form a SUMO E3 ligase family defined by a RING zinc finger motif (Johnson et al., 2001) . PIAS proteins function in transcriptional regulation through various mechanisms in animals (Cobenas-Potts and Matunis, 2013). In plants, it is unknown whether and how PIAS homologs are involved in transcriptional regulation. In this study, we found that the Arabidopsis SUMO E3 ligase-like proteins PIAL1 and PIAL2 interact with the plant-specific protein MOM1 and thus mediate transcriptional silencing, suggesting that the molecular mechanism underlying the function of PIAL1 and PIAL2 in plants is different from that of PIAS proteins in animals. This study revealed a novel mechanism by which SUMO E3 ligase-like proteins contribute to transcriptional silencing in plants.
SUMO E3 ligases interact with substrates and SUMO proteins, thereby facilitating sumoylation of substrates in animals (Gareau and Lima, 2010). PIAL1 and PIAL2 were shown to have SUMO ligase activity, which is required for SUMO chain formation (Tomanov et al., 2014) . Although the RING and SIM domains are necessary for the SUMO ligase activity of PIAL2, they are dispensable for transcriptional silencing (Figure 6A-6C) . Thus, the SUMO ligase activity of PIAL2 is not required for the function of PIAL2 in transcriptional silencing. This result is consistent with the finding that MOM1
is not sumoylated in vivo ( Figure 6E ). Together, these results suggest that PIAL2 serves as an interaction partner of MOM1 rather than as a SUMO ligase for MOM1.
MOM1 contains a domain that is distantly related to the catalytic SNF2 domain in chromatinremodeling proteins (Amedeo et al., 2000) . The full SNF2 domain is composed of seven conserved DNA helicase motifs and is required for the function of chromatin-remodeling proteins (Thoma et al., 2005) . However, the SNF2-related domain in MOM1 is dispensable for the function of MOM1 in transcriptional silencing (Caikovski et al., 2008) . Instead, CMM2, a conserved MOM1 motif, is not only necessary but is also sufficient for transcriptional silencing at a subset of MOM1 target loci (Caikovski et al., 2008; Nishimura et al., 2012) . The CMM2 domain forms a homodimer as determined by X-ray crystallography (Nishimura et al., 2012 ). Our results demonstrate that the CMM2 domain is required not only for forming a homodimer but also for interacting with PIAL1 and PIAL2 ( Figure 5A-5E ). The dual functions of the CMM2 domain are consistent with the finding that this domain plays a critical role in transcriptional silencing (Caikovski et al., 2008; Nishimura et al., 2012) . Our results suggest that PIAL1 20 and PIAL2 interact with each other and with MOM1 to form a novel PIAL1/2-and MOM1-containing complex in vivo. Considering that PIAL1 and PIAL2 are necessary for transcriptional silencing at most MOM1 target loci, we predict that the integrity of the complex is required for transcriptional silencing.
The involvement of MOM1 in transcriptional silencing is independent of changes in DNA methylation in heterochromatin regions and remains a poorly understood silencing mechanism in plants (Habu et al, 2006; Vaillant et al., 2006; Yokthongwattana et al., 2010) . Previous reports showed that SUMO proteins and SUMO-conjugating enzymes mediate transcriptional repression at heterochromatin regions in yeast and animals (Shin et al., 2005; Shiio et al. 2003; Nathan et al., 2006) , but it is unknown whether and how these proteins function at heterochromatin regions in plants. Our results demonstrate that the SUMO ligase-like proteins PIAL1 and PIAL2 interact with each other and with MOM1 to form a high-molecular-weight complex ( Figure 4A-4C ). Although we demonstrate that the SUMO ligase activity is not required for the function of PIAL2 in transcriptional silencing ( Figure (Budhiraja et al., 2009; Miller et al., 2010; Miller et al., 2013) . Sumoylation is probably necessary for these silencing regulators to function in transcriptional silencing. MOM1 was previously shown to be functionally linked to the RdDM pathway (Numa et al., 2010; Yokthongwattana et al., 2010) . It is possible that the PIAL1/2-MOM1 complex cooperates with these sumoylated silencing regulators and thereby facilitates transcriptional silencing on chromatin.
MATERIALS AND METHODS
Plant materials and growth conditions
Arabidopsis thaliana seedlings were grown on MS (Murashige and Skoog) medium plates under standard long-day conditions (16 h/light, 8 h/dark, 22°C). The T-DNA insertion mutants pial2 (SALK_043892), pial1 (CS358389), and mom1-3 (SALK_141293) were in the Col-0 background and obtained from the Arabidopsis Biological Resource Center. The ros1 mutant in the C24 background harboring both pRD29A-LUC and p35S-NPTII transgenes was previously reported (Gong et al., 2002) .
The ros1/pial2 mutant was generated by crossing the ros1and pial2 single mutants. For luminescence 21 imaging, seedlings were grown on MS medium for 10 days and then kept at 4°C for 2 days to activate the stress-responsive pRD29A-LUC transgene. Following the cold treatment, the seedlings were sprayed with luciferin and subjected to luminescence imaging.
The full-length of PIAL1, PIAL2 or MOM1 driven by the corresponding native promoter was introduced into the modified pCAMBIA1305 or pRI909 vector to express the C-terminal 5xMyc-or 3xFlag-tagged proteins. The constructs were introduced into the Agrobacterium strain GV3101 and transformed into Arabidopsis by the flower-dipping method (Clough and Bent, 1998) . Site-directed mutagenesis was performed to introduce point mutations into the epitope-tagged PIAL2 and MOM1 constructs, and the function of the mutated PIAL2 and MOM1 proteins was then determined by complementation testing. In the N-terminal Flag-tagged PIAL2 construct, the PIAL2 native promoter was placed in front of the Flag-tag sequence in the pRI909 vector. All constructs were sequenced for verification, and the primers used for the construction are listed in Supplemental Data Set 8.
RT-PCR, RT-qPCR, and RNA deep sequencing
Total RNA was extracted with Trizol reagent (Invitrogen) from 10-day-old Arabidopsis seedlings or from rosette leaves. The cDNA was obtained using a Reverse Transcription Kit (TaKaRa, RR012A). RTqPCR was performed with SYBR Green Master Mix (TaKaRa) according to the manufacturer's instruction. The actin gene ACT7 was used as an internal control. The primers used for RT-PCR are listed in Supplemental Data Set 8. Total RNA was extracted from two-week-old Arabidopsis seedlings and then used to produce RNA libraries for deep sequencing (HiSeq 2000, Illumina) . To analyze the data, the Arabidopsis genome sequences and annotated gene models were downloaded from TAIR10 (http://www.arabidopsis.org/). After the adaptor sequences were removed, 49-bp reads were mapped to the TAIR10 Arabidopsis genome using Tophat (v2.0.12, http://ccb.jhu.edu/software/tophat/), allowing up to two mismatches. Cufflinks (v2.2.1, http://cole-trapnell-lab.github.io/cufflinks/) was performed to assemble transcripts and calculate transcript abundances. Gene expression differences were evaluated using a combination of Fisher's exact test (P < 0.01) and the fold change of the normalized reads (Log2(fold change) > 1). The gplots package in R was used to draw the heat maps of the differentially expressed genes and TEs. The quantsmooth package in Bioconductor was modified to draw the distribution of up-regulated TEs throughout the five Arabidopsis chromosomes. The raw RNA deep sequencing data have been deposited in the Gene Expression Omnibus (GEO) database (accession no.
GSE80303).
Whole-genome DNA methylation analysis
For whole-genome DNA methylation analysis, genomic DNA was extracted from the two-week-old Arabidopsis seedlings with hexadecyltrimethyl ammonium bromide (CTAB) and subjected to bisulfite treatment that converted unmethylated cytosine to uracil. The converted genomic DNA was amplified and then used for whole-genome bisulfite sequencing with HiSeq 2000 (Illumina). Bisulfite sequencing reads were mapped to the TAIR10 reference genome using Bismark, allowing two mismatches (Krueger and Andrews, 2011) . Reads that were mapped to more than one position were removed to retain only reads that were uniquely mapped. The methylation level of each cytosine site was represented by the percentage of the number of reads reporting a C relative to the total number of reads reporting a C or T.
Only sites with at least five-fold coverage were included in the results. Gene and TE annotations were downloaded from TAIR. The methylation levels of genes and TEs were estimated by pooling the read counts that show at least five-fold coverage. The method for identifying differentially methylated regions (DMRs) was previously described (Stroud et al., 2013) . Bins of 200 base pair were analyzed and the DNA methylation levels of total cytosine, CG, CHG, and CHH sites were separately evaluated. Bins were considered DMRs when the absolute DNA methylation change was more than 10%, 40%, 20%, and 10% for total C, CG, CHG, and CHH, respectively. We compared the DNA methylation levels between each mutant and three different wild-type controls to obtain three batches of DMRs. Only those DMRs identified in the mutant relative to all three controls were selected for further analysis. Wholegenome DNA methylation of Col-0 was determined by bisulfite sequencing analysis two times and the data were used for two wild-type controls; another wild-type control was from a previous report (Stroud et al., 2013) . To evaluate the correlation between expression and DNA methylation, we determined the DNA methylation levels of different classes of differentially expressed loci. The raw bisulfite sequencing data have been deposited in the Gene Expression Omnibus (GEO) database (accession no.
GSE80303).
Affinity purification, mass spectrometric analysis, co-immunoprecipitation, and gel filtration For affinity purification, 6 g of flower tissue was ground to a fine powder and then suspended in lysis buffer (50 mM Tris-HCl [pH 7.6], 150 mM NaCl, 5 mM MgCl2, 10% glycerol, 0.1% NP-40, 0.5 mM DTT, 1 mM PMSF, and 1 protease inhibitor cocktail tablet/50 ml [Roche] ). The supernatant obtained by 23 centrifugation was incubated with anti-Flag antibody-conjugated beads (Sigma, A2220) for 2.5 h at 4°C.
After the beads were vigorously washed several times, the proteins was eluted with 3xFLAG peptides (Sigma, F4799), and separated on a 7.5% SDS-PAGE gel. The gel was stained with the ProteoSilver Silver Stain Kit (Sigma PROT-SIL1), and the bands were then subjected to mass spectrometric analysis.
For co-immunoprecipitation, the protein extracted from flower tissue or from seedlings was incubated with anti-Flag M1 agarose (Sigma, A2220) for affinity purification. After the sample was washed, it was boiled and subjected to SDS-PAGE and then to immunoblotting. For gel filtration, 0.5 g of seedlings was ground to a powder and suspended in 2 ml of lysis buffer. After centrifugation, the supernatant was passed through a 0.22-micron filter, and 500 μl of the filtrate was loaded onto a Superose 6 (10/300 GL) column (GE Healthcare, 17-5172-01). The eluate was collected in a series of fractions (500 μl/fraction) and run on SDS-PAGE gel for immunoblotting.
Yeast two-hybrid assay
The cDNA sequences and the different truncated forms of MOM1, PIAL1, and PIAL2 were cloned into pGADT7 and pGBKT7 vectors in frame to the 3'-termini of GAL4-AD and GAL4-BD using the One-step mg/L chloromycetin) and grown at 37°C with rapid shaking (>200 rpm) overnight. A 1-ml volume of the LB was then added to 100 ml of LB for growth under the same conditions. When the OD 600 of the culture increased to 0.4-0.5, 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added, and then the culture was shaken continuously at 18°C for another 24 h for protein induction.
The bacteria in the culture were collected by centrifugation, and 4 ml of the bacterial culture was suspended in 1.5 ml of protein extraction buffer (50 mM Tris-HCl [pH 8.0], 300 mM NaCl, 10% glycerol, 0.5% Tween-20, 15 mM β-mercaptoethanol, 1 mM PMSF, and 1 protease inhibitor cocktail tablet/50 ml [Roche]). The sample was sonicated four times (10 s on and 59 s off), and then centrifuged at 13000 rpm for 10 min at 4°C. A 1.4-ml volume of the supernatant was transferred to a 1.5-ml
Eppendorf tube. Of this supernatant, 200 μl was used as input, and 1.2 ml was incubated with 50 μl of GST-beads for a pull-down assay. After incubation for 1.5 h with gentle rotation at 4°C, the sample was centrifuged at 2000 rpm for 1 min at 4°C. The supernatant was discarded and the GST-beads were washed six times (5 min per time) with 1.5 ml of protein extraction buffer at 4°C. After the last wash, 200 μl of protein extraction buffer and 50 μl of 5xSDS sample buffer were added to the tube. The samples were boiled for 6 min at 100°C and separated on 15% SDS-PAGE gels for immunoblotting with GST antibody (Abmart, 12G8) and HIS antibody (Abmart, 10E2).
In vitro sumoylation assay
All proteins used in the in vitro sumoylation assay were expressed and purified in E. coli using Rosetta (DE3). SUMO1 was expressed in pET28a vector with a C-terminal His tag, and was purified with Ni beads, followed by removal of His tag with Ulp1 enzyme. SAE1b was expressed in pETDuet-1 vector with no tags, while SAE2 was expressed in a modified pET28a vector with an N-terminal His tag followed by a PreScission Site. The two subunits of E1 enzyme (SAE1b and SAE2) were co-expressed in Rosetta (DE3) and purified with Ni 2+ beads followed by His tag removal using PreScission Protease. The E2 enzyme SCE1 was expressed in a modified pET28a vector with a His tag followed by PreScission Site in the N terminal, and was purified with Ni 2+ beads followed by His tag removal. PIAL2 and its mutants were tagged with hexa-His in the N terminal and were purified with Ni 2+ beads.
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The in vitro sumoylation reaction buffer contained 50 mM Tris-HCl (pH 7.6), 100 mM NaCl, 15%
glycerol, 5 mM ATP, and 5 mM MgCl 2 . For the assay, 8 µg SUMO1 was incubated with 0.5 µg E1 enzyme, 4 µg E2 enzyme, and 1 µg PIAL2 or its mutant for 2 h at 37°C. The total volume of the reaction was 50 µl. The samples were then separated by SDS-PAGE and analyzed by immunoblotting for detection of sumoylated bands.
Accession Numbers
Sequence data from this article can be found in the Arabidopsis Genome Initiative or GenBank/EMBL databases under the following accession numbers: PIAL1 ( 
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